title: Quality of life and hepatocellular carcinoma.
abstract: Hepatocellular carcinoma (HCC) is a common and rapidly fatal cancer ranking third among the leading causes of cancer-related deaths. Potentially curative therapies like surgery, transplant and ablation are not an option for most patients as they are often diagnosed when the disease is advanced. Liver directed therapy and oral targeted therapies are used in these patients to prolong life and palliate symptoms of the cancer and associated liver failure. Overall survival remains poor and hence health-related quality of life (HRQoL) is of paramount importance in these patients. As novel therapies are developed to improve outcomes, a comprehensive knowledge of available tools to assess impact on QoL is needed. Hence we reviewed all the studies in HCC patients published within the last 13 years from 2001-2013 which assessed HRQoL as a primary or secondary endpoint. A total of 45 studies and 4 meta-analysis were identified. Commonly used tools were European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30) (15 studies) and the Functional Assessment of Cancer Therapy-Hepatobiliary Questionnaire (FACT-Hep) (14 studies). Of the 45 publications which incorporated HRQoL as end-point only 24 were clinical trials, 17/24 (71%) assessed systemic therapies while 7/24 (29%) assessed liver-directed therapies. Majority of the publications (trials + retrospective reviews) that had HRQoL as an endpoint in HCC patients were studies evaluating liver-directed therapies (23/45 or >50%). We discuss the measures included in the tools, their interpretation, and summarize existing QoL data that will help design future HCC trials.
authors.affiliation: 1 Department of Internal Medicine, University at Buffalo, NY, USA ; 2 Department of Oncology, Roswell Park Cancer Institute, Buffalo, NY, USA.
authors.forename: Shipra
authors.initials: S
authors.lastname: Gandhi
authors.affiliation: 1 Department of Internal Medicine, University at Buffalo, NY, USA ; 2 Department of Oncology, Roswell Park Cancer Institute, Buffalo, NY, USA.
authors.forename: Sapna
authors.initials: S
authors.lastname: Khubchandani
authors.affiliation: 1 Department of Internal Medicine, University at Buffalo, NY, USA ; 2 Department of Oncology, Roswell Park Cancer Institute, Buffalo, NY, USA.
authors.forename: Renuka
authors.initials: R
authors.lastname: Iyer
keywords: Hepatocellular carcinoma (HCC); endpoint; health-related quality of life (HRQoL); trial
references.citation: Eur J Nucl Med Mol Imaging. 2002 Oct;29(10):1374-9
references.pmid: 12271421
references.citation: Hepatobiliary Pancreat Dis Int. 2004 Nov;3(4):530-3
references.pmid: 15567739
references.citation: Hepatology. 2003 Feb;37(2):429-42
references.pmid: 12540794
references.citation: Semin Oncol. 1994 Oct;21(5 Suppl 10):48-60; discussion 60-3
references.pmid: 7973770
references.citation: Gastroenterology. 2008 May;134(6):1752-63
references.pmid: 18471552
references.citation: Br J Cancer. 2011 Sep 27;105(7):945-52
references.pmid: 21863030
references.citation: World J Gastroenterol. 2012 Jun 7;18(21):2689-94
references.pmid: 22690079
references.citation: CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
references.pmid: 15761078
references.citation: Qual Life Res. 2008 Aug;17(6):831-43
references.pmid: 18618292
references.citation: Eur J Surg Oncol. 2006 Mar;32(2):201-7
references.pmid: 16373084
references.citation: Qual Life Res. 2007 Mar;16(2):203-15
references.pmid: 17119847
references.citation: J Surg Oncol. 2007 Jan 1;95(1):34-9
references.pmid: 17192864
references.citation: N Engl J Med. 2008 Jul 24;359(4):378-90
references.pmid: 18650514
references.citation: Gut. 1998 Mar;42(3):442-7
references.pmid: 9577356
references.citation: Oncol Nurs Forum. 2008 Jul;35(4):643-50
references.pmid: 18591168
references.citation: Med Care. 1996 Mar;34(3):220-33
references.pmid: 8628042
references.citation: Gastrointest Cancer Res. 2008 May;2(3 Suppl):S25-31
references.pmid: 19352465
references.citation: World J Gastroenterol. 2007 Jun 21;13(23):3164-70
references.pmid: 17589893
references.citation: Lancet Oncol. 2009 Jan;10(1):25-34
references.pmid: 19095497
references.citation: Cancer. 2006 Dec 1;107(11):2715-22
references.pmid: 17075874
references.citation: BMC Cancer. 2010 Aug 24;10:457
references.pmid: 20735834
references.citation: Ann Oncol. 2006 Feb;17(2):304-12
references.pmid: 16357021
references.citation: J Rheumatol. 2005 May;32(5):811-9
references.pmid: 15868614
references.citation: Eur J Cancer. 2008 Mar;44(4):528-38
references.pmid: 18242076
references.citation: Qual Life Res. 2005 Mar;14(2):539-47
references.pmid: 15892443
references.citation: Psychooncology. 2013 Jun;22(6):1353-60
references.pmid: 22847677
references.citation: J Gastroenterol Hepatol. 2007 Feb;22(2):197-203
references.pmid: 17295871
references.citation: Arch Surg. 2001 Jun;136(6):693-9
references.pmid: 11387012
references.citation: Eur J Cancer. 2004 Nov;40(16):2439-44
references.pmid: 15519517
references.citation: Hepatology. 2002 Nov;36(5):1221-6
references.pmid: 12395333
references.citation: Clin J Oncol Nurs. 2004 Aug;8(4):393-9
references.pmid: 15354926
references.citation: Dig Liver Dis. 2010 Jul;42 Suppl 3:S206-14
references.pmid: 20547305
references.citation: Surgery. 2007 Nov;142(5):676-84
references.pmid: 17981187
references.citation: J Clin Oncol. 2005 Jul 1;23(19):4338-46
references.pmid: 15994145
references.citation: J Natl Cancer Inst. 1993 Mar 3;85(5):365-76
references.pmid: 8433390
references.citation: Ann Oncol. 2006 Jul;17(7):1083-9
references.pmid: 16600982
references.citation: Ai Zheng. 2005 Jul;24(7):827-33
references.pmid: 16004809
references.citation: Hepatology. 2002 Sep;36(3):687-91
references.pmid: 12198662
references.citation: BMJ. 1992 Aug 22;305(6851):466-9
references.pmid: 1392964
references.citation: J Clin Oncol. 2002 May 1;20(9):2229-39
references.pmid: 11980994
references.citation: Mayo Clin Proc. 2002 Apr;77(4):384-92
references.pmid: 11936936
references.citation: Br J Cancer. 2007 Sep 3;97(5):582-8
references.pmid: 17687341
references.citation: Qual Life Res. 2007 Apr;16(3):389-97
references.pmid: 17111232
references.citation: Eur J Cancer. 2002 Mar;38 Suppl 4:S125-33
references.pmid: 11858978
references.citation: Eur J Cancer. 2009 Jul;45(10):1788-97
references.pmid: 19303768
references.citation: J Hepatol. 2013 Mar;58(3):509-21
references.pmid: 23178978
references.citation: Br J Cancer. 1990 Oct;62(4):695-9
references.pmid: 2223593
references.citation: Qual Life Res. 2005 May;14(4):1025-33
references.pmid: 16041898
references.citation: Psychooncology. 2004 Feb;13(2):73-9
references.pmid: 14872525
references.citation: Ann Oncol. 1995 Sep;6(7):645-9
references.pmid: 8664184
references.citation: J Pain Symptom Manage. 2002 Jul;24(1):32-44
references.pmid: 12183093
references.citation: Support Care Cancer. 2007 Mar;15(3):279-86
references.pmid: 16944218
references.citation: Hepatogastroenterology. 2002 Sep-Oct;49(47):1245-50
references.pmid: 12239914
references.citation: Hepatogastroenterology. 2001 Mar-Apr;48(38):506-10
references.pmid: 11379343
references.citation: Hepatogastroenterology. 2010 Mar-Apr;57(98):292-9
references.pmid: 20583430
references.citation: Mayo Clin Proc. 2002 Apr;77(4):371-83
references.pmid: 11936935
references.citation: Ann Oncol. 1998 May;9(5):549-57
references.pmid: 9653497
references.citation: Clin Oncol (R Coll Radiol). 2006 Nov;18(9):684-92
references.pmid: 17100154
references.citation: Aliment Pharmacol Ther. 2004 Apr 1;19(7):779-88
references.pmid: 15043519
references.citation: Dig Liver Dis. 2003 Jan;35(1):46-54
references.pmid: 12725608
references.citation: J Natl Cancer Inst. 2005 Oct 5;97(19):1407-27
references.pmid: 16204691
references.citation: Oncologist. 2012;17(5):732-9
references.pmid: 22511265
references.citation: Hepatogastroenterology. 2002 Mar-Apr;49(44):492-6
references.pmid: 11995480
references.citation: J Clin Oncol. 1993 Mar;11(3):570-9
references.pmid: 8445433
references.citation: N Engl J Med. 1981 Oct 22;305(17):982-7
references.pmid: 7278922
references.citation: Br J Cancer. 2006 Oct 9;95(7):853-61
references.pmid: 16953241
references.citation: Am J Clin Oncol. 2003 Aug;26(4):344-9
references.pmid: 12902882
references.citation: Oncol Rep. 2002 Jul-Aug;9(4):903-7
references.pmid: 12066229
references.citation: Int J Radiat Oncol Biol Phys. 2008 Apr 1;70(5):1447-52
references.pmid: 17996394
references.citation: Hepatobiliary Pancreat Dis Int. 2008 Jun;7(3):237-57
references.pmid: 18522878
references.citation: Qual Life Res. 2005 Apr;14(3):875-82
references.pmid: 16022079
references.citation: Qual Life Res. 2006 Feb;15(1):15-24
references.pmid: 16411027
references.citation: Cancer. 2005 Nov 15;104(10):2234-43
references.pmid: 16220558
references.citation: Clin J Oncol Nurs. 2008 Feb;12(1):65-77
references.pmid: 18258576
references.citation: J Clin Oncol. 2013 Nov 1;31(31):3980-6
references.pmid: 24062394
references.citation: J Vasc Interv Radiol. 2010 Jul;21(7):1024-30
references.pmid: 20621715
references.citation: Hepatology. 2007 Jan;45(1):9-15
references.pmid: 17187405
references.citation: Oncol Nurs Forum. 2008 May;35(3):E45-52
references.pmid: 18467279